(Q46433354)

22 December 2017

title

Adiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones (English)

1 reference

22 December 2017

1 reference

2

1 reference

22 December 2017

Michael Stumvoll

5

object named as

Stumvoll M

1 reference

22 December 2017

6

Machicao F

1 reference

22 December 2017

Hans-Ulrich Häring

7

object named as

Häring HU

1 reference

22 December 2017

author name string

Kaltenbach S

1

1 reference

22 December 2017

Weisser M

3

1 reference

22 December 2017

Haas C

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

International Journal of Obesity

published in

1 reference

22 December 2017

volume

29

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

760-765

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0802957

exact match

0 references

cites work

Adiponectin: more than just another fat cell hormone?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Thiazolidinediones -- some recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Troglitazone action is independent of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Adipogenesis and obesity: rounding out the big picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802957

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJO.0802957

1 reference

22 December 2017

1 reference

22 December 2017